Therefore, we proposed to assign HCPCS code G0562 to APC 1514 (New TechnologyLevel 14 ($1201-$1300) with a payment rate of $1,250.50 for CY 2026
Efficacy and safety of adding once-weekly dulaglutide to basal insulin for inadequately controlled type 2 diabetes in Chinese patients (AWARD-CHN3): A randomized, double-blind, placebo-controlled, phase III trial
Of note, a small number of cases of acute pancreatitis associated with GLP-1RA use have been reported in clinical trials: 38 cases in 17,775 patient-years of exposure compared with 9 events in 5863 patient-years of exposure with the comparator treatment
Disclaimer: Laboratory testing is informational and should be interpreted with symptoms, medical history, medication use, and guidance from a qualified healthcare provider
You might notice a smoother-feeling texture and improved comfort within the first few weeks